New hope for cardiac arrest survivors: drug aims to calm deadly inflammation
NCT ID NCT07176754
Summary
This study is testing if a drug that blocks a specific inflammation signal (TNF-a) can help people who are still unconscious after their heart is restarted. The goal is to see if giving this drug within hours of revival improves the chance of surviving for 30 days and having good brain function. Researchers will compare the drug to a placebo in 208 patients to see if it controls the body's harmful overreaction to the cardiac arrest.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST (CA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.